Teletherapy could miss a distinct group among patients with pain and opioid use disorder
Abstract The COVID-19 pandemic highlighted a pre-existing issue related to healthcare accessibility, especially for comorbid chronic pain and opioid use disorder (OUD) populations. Though researchers and practitioners have relied on telehealth to address barriers to healthcare, telehealth services r...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-11-01
|
| Series: | Discover Psychology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s44202-024-00300-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850129007229534208 |
|---|---|
| author | Sarah C. Wilson Alexandra M. Otto Amy B. Wachholtz |
| author_facet | Sarah C. Wilson Alexandra M. Otto Amy B. Wachholtz |
| author_sort | Sarah C. Wilson |
| collection | DOAJ |
| description | Abstract The COVID-19 pandemic highlighted a pre-existing issue related to healthcare accessibility, especially for comorbid chronic pain and opioid use disorder (OUD) populations. Though researchers and practitioners have relied on telehealth to address barriers to healthcare, telehealth services remain inaccessible for many. This study explored the effectiveness of strategies used to continue a clinical trial for comorbid chronic pain and OUD during the COVID-19 pandemic. This study involved the transition of in-person group psychotherapy (Self-regulation Therapy for Opioid use disorder and Chronic Pain–STOP) to telehealth. We completed a mixed-method data analysis to assess the differences between the telehealth and in-person administrations. Though the telehealth group showed higher retention, the in-person group reached more diverse samples. Participants who completed the telehealth group had higher education and income, longer periods of stability on medication for opioid use disorder (MOUD) and were more likely to be White compared to participants who completed the in-person group. Individuals from minoritized and underserved groups who lack access to in-person services may fall through the gaps of healthcare in the shift to telehealth. There is a clear need for additional research on how to best support those who lack access to current comorbid chronic pain and OUD treatment modalities. ClinicalTrials.gov record number:17–1849, registered November 2017. |
| format | Article |
| id | doaj-art-49a40cf418c8461dbc4bca487d67d03c |
| institution | OA Journals |
| issn | 2731-4537 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Springer |
| record_format | Article |
| series | Discover Psychology |
| spelling | doaj-art-49a40cf418c8461dbc4bca487d67d03c2025-08-20T02:33:08ZengSpringerDiscover Psychology2731-45372024-11-01411710.1007/s44202-024-00300-9Teletherapy could miss a distinct group among patients with pain and opioid use disorderSarah C. Wilson0Alexandra M. Otto1Amy B. Wachholtz2Department of Psychology, University of Colorado DenverDepartment of Psychology, University of Colorado DenverDepartment of Psychology, University of Colorado DenverAbstract The COVID-19 pandemic highlighted a pre-existing issue related to healthcare accessibility, especially for comorbid chronic pain and opioid use disorder (OUD) populations. Though researchers and practitioners have relied on telehealth to address barriers to healthcare, telehealth services remain inaccessible for many. This study explored the effectiveness of strategies used to continue a clinical trial for comorbid chronic pain and OUD during the COVID-19 pandemic. This study involved the transition of in-person group psychotherapy (Self-regulation Therapy for Opioid use disorder and Chronic Pain–STOP) to telehealth. We completed a mixed-method data analysis to assess the differences between the telehealth and in-person administrations. Though the telehealth group showed higher retention, the in-person group reached more diverse samples. Participants who completed the telehealth group had higher education and income, longer periods of stability on medication for opioid use disorder (MOUD) and were more likely to be White compared to participants who completed the in-person group. Individuals from minoritized and underserved groups who lack access to in-person services may fall through the gaps of healthcare in the shift to telehealth. There is a clear need for additional research on how to best support those who lack access to current comorbid chronic pain and OUD treatment modalities. ClinicalTrials.gov record number:17–1849, registered November 2017.https://doi.org/10.1007/s44202-024-00300-9PainOpioid use disorderTelehealthInclusion |
| spellingShingle | Sarah C. Wilson Alexandra M. Otto Amy B. Wachholtz Teletherapy could miss a distinct group among patients with pain and opioid use disorder Discover Psychology Pain Opioid use disorder Telehealth Inclusion |
| title | Teletherapy could miss a distinct group among patients with pain and opioid use disorder |
| title_full | Teletherapy could miss a distinct group among patients with pain and opioid use disorder |
| title_fullStr | Teletherapy could miss a distinct group among patients with pain and opioid use disorder |
| title_full_unstemmed | Teletherapy could miss a distinct group among patients with pain and opioid use disorder |
| title_short | Teletherapy could miss a distinct group among patients with pain and opioid use disorder |
| title_sort | teletherapy could miss a distinct group among patients with pain and opioid use disorder |
| topic | Pain Opioid use disorder Telehealth Inclusion |
| url | https://doi.org/10.1007/s44202-024-00300-9 |
| work_keys_str_mv | AT sarahcwilson teletherapycouldmissadistinctgroupamongpatientswithpainandopioidusedisorder AT alexandramotto teletherapycouldmissadistinctgroupamongpatientswithpainandopioidusedisorder AT amybwachholtz teletherapycouldmissadistinctgroupamongpatientswithpainandopioidusedisorder |